Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Telomerase inhibitors under study at Pharmacia

Dec. 13, 2002

Inhibition of Src tyrosine kinases as a novel approach to the treatment of CML

Dec. 12, 2002

Exherin cleared to enter phase I trials in Canada

Dec. 12, 2002

NanoCarrier and Kirin collaborate on anticancer therapeutics

Dec. 12, 2002

Apomine as a new therapeutic approach to multiple myeloma

Dec. 12, 2002

New caspase activators in Cytovia development pipeline

Dec. 12, 2002

Pipecolinate MDR modulators effective in modulating mitoxantrone efflux from AML cells

Dec. 11, 2002

HDAC inhibitor active against multiple myeloma in vitro and in animal model

Dec. 11, 2002

Antitumor activity of Geron's telomerase inhibitor reported in presentation at ASH meeting

Dec. 11, 2002

New proline-based MMP inhibitors in early development at Aventis

Dec. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...